172 related articles for article (PubMed ID: 35543545)
1. Analytically confirmed presence of psychoactive substances, especially new psychoactive substances in a group of patients hospitalized with mental and behavioural disorders due to the use of psychoactive substances diagnosis.
Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A
Int J Occup Med Environ Health; 2022 Aug; 35(4):485-495. PubMed ID: 35543545
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities.
Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A; Kowalkowski T
Int J Occup Med Environ Health; 2020 Mar; 33(2):125-136. PubMed ID: 31942874
[TBL] [Abstract][Full Text] [Related]
3. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
5. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
Franz F; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of third generation synthetic cannabinoids using zebrafish larvae.
Morales-Noé A; Esteve-Turrillas FA; Armenta S
Drug Test Anal; 2022 Apr; 14(4):594-603. PubMed ID: 34750997
[TBL] [Abstract][Full Text] [Related]
7. Sewage analysis as an alternative tool for assessing drug of abuse and new psychoactive substances in Tunisia.
Moslah B; Smaoui O; Nouioui MA; Araoud M; Chaouali N; Laribi M; Amira D; Ben Salah N; Hedhili A
Forensic Sci Int; 2023 Jun; 347():111672. PubMed ID: 37023613
[TBL] [Abstract][Full Text] [Related]
8. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
[TBL] [Abstract][Full Text] [Related]
9. Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.
Gundersen POM; Spigset O; Josefsson M
Drug Test Anal; 2019 Jan; 11(1):51-67. PubMed ID: 29996011
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
Niebel A; Pragst F; Krumbiegel F; Hartwig S
Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
[TBL] [Abstract][Full Text] [Related]
11. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
Bäckberg M; Tworek L; Beck O; Helander A
J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
[TBL] [Abstract][Full Text] [Related]
12. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
13. Application of a simultaneous screening method for the detection of new psychoactive substances in various matrix samples using liquid chromatography/electrospray ionization tandem mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.
Kim NS; Lim NY; Choi HS; Lee JH; Kim H; Baek SY
Rapid Commun Mass Spectrom; 2021 May; 35(10):e9067. PubMed ID: 33656207
[TBL] [Abstract][Full Text] [Related]
14. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
[TBL] [Abstract][Full Text] [Related]
15. Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.
Beck O; Franzen L; Bäckberg M; Signell P; Helander A
Clin Toxicol (Phila); 2015 Nov; 53(9):865-73. PubMed ID: 26462932
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department.
Weng TI; Chen LY; Chen JY; Chen PS; Hwa HL; Fang CC
J Formos Med Assoc; 2020 Dec; 119(12):1827-1834. PubMed ID: 32037264
[TBL] [Abstract][Full Text] [Related]
17. Frequency of new psychoactive substances in hair and urine samples of individuals subject to drug testing in driving license regranting-A toxicological perspective.
Fels H; Musshoff F; Graw M; DeVol D; Wagner T; Holzer A
Drug Test Anal; 2023 Aug; 15(8):919-926. PubMed ID: 37332090
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
19. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
[TBL] [Abstract][Full Text] [Related]
20. Trends in the Pharmaceutical Design of New Psychoactive Substances Detected in Oral Fluid OF Drivers Around a Music Festival in South-West France: Comparison 2019/2017.
Gish A; Dumestre-Toulet V; Richeval C; Wiart JF; Hakim F; Allorge D; Gaulier JM
Curr Pharm Des; 2022; 28(15):1245-1249. PubMed ID: 35585812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
